![Daniel F. Voytas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel F. Voytas
Corporate Officer/Principal presso
University of Minnesota
Profilo
Daniel F.
Voytas was the founder of Calyxt, Inc. which was founded in 2010, where he held the title of Chief Science Officer from 2010 to 2021.
Currently, he is the Director-Center for Precision Plant Genomics at the University of Minnesota since 2008.
Dr. Voytas received his doctorate degree from Harvard Medical School in 1990 and his undergraduate degree from Harvard College in 1984.
Posizioni attive di Daniel F. Voytas
| Società | Posizione | Inizio |
|---|---|---|
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2008 |
Precedenti posizioni note di Daniel F. Voytas
| Società | Posizione | Fine |
|---|---|---|
Calyxt, Inc.
 Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Fondatore | 01/02/2021 |
Formazione di Daniel F. Voytas
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Commercial Services |
